Cargando…
Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy
REP 2139 is a nucleic acid polymer (NAP) currently under clinical development for chronic hepatitis B (HBV) therapy. This preclinical study investigated different REP 2139 analogs that would display reduced accumulation in the serum and tissues, while retaining an antiviral effect against HBV infect...
Autores principales: | Roehl, Ingo, Seiffert, Stephan, Brikh, Celia, Quinet, Jonathan, Jamard, Catherine, Dorfler, Nadine, Lockridge, Jennifer A., Cova, Lucyna, Vaillant, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466589/ https://www.ncbi.nlm.nih.gov/pubmed/28918011 http://dx.doi.org/10.1016/j.omtn.2017.04.019 |
Ejemplares similares
-
Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks
por: Quinet, Jonathan, et al.
Publicado: (2018) -
Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication
por: Ndeboko, Bénédicte, et al.
Publicado: (2017) -
Editorial: In vitro mechanistic evaluation of nucleic acid polymers: A cautionary tale
por: Vaillant, Andrew
Publicado: (2022) -
Therapeutic Potential of Cell Penetrating Peptides (CPPs) and Cationic Polymers for Chronic Hepatitis B
por: Ndeboko, Bénédicte, et al.
Publicado: (2015) -
Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway
por: Ndeboko, Bénédicte, et al.
Publicado: (2018)